HOME >> BIOLOGY >> NEWS
Role in Type 1 diabetes provides clue for researchers who discovered 'obesity gene'

The discovery of a gene believed to be connected to morbid obesity has international origins and began as an exploration into the causes of Type I diabetes.

The discovery, which will be published in an upcoming issue of the journal Public Library of Science (http://www.plos.org), involves researchers originally from Sweden and France who collaborated at the University of Washington in Seattle.

The gene, on Chromosome 10, was first connected to diabetes in 1991 by Dr. ke Lernmark, R. H. Williams Professor of Medicine and adjunct professor of immunology at the UW. The GAD2 gene is responsible for the protein GAD65, which plays a role in the healthy use of insulin by the body. Lernmark is a native of Sweden, which has one of the highest rates of Type I diabetes incidence in the world.

Lernmark is a native of Sweden, which has one of the highest rates of Type I diabetes incidence in the world. In 1997, Lernmark was joined in his laboratory at the University of Washington by Professor Philippe Froguel as a Poll Visiting Scholar.*

Froguel, senior author of the research, is based at Imperial College London, and Hammersmith Hospital, London, and carried out the research while at the Institut Pasteur de Lille in France. Froguel and colleagues had previously determined that obese people often had genetic variations in Chromosome 10, with individual variations showing up in the GAD2 gene.

During and since the stay at the Lernmark lab, the researchers have collaborated ever since the GAD2 gene was first considered as a candidate obesity gene. The researchers believe that GAD2 produces the protein GAD65 that catalyzes the production of a neurotransmitter in the hypothalamus that stimulates or suppresses appetite.

Lermark says that several years ago, he and his colleagues in Sweden found that some obese people had antibodies to GAD65. This finding remained unexplained, but sparked Froguel's interest when he was searc
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
3-Nov-2003


Page: 1 2

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. A probable cause for high blood pressure identified - shows links with diabetes
4. Joslin President awarded medal from international diabetes organization
5. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
6. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
7. Genetic mutation found that is major contributor to type 1 diabetes
8. Joslin researchers identify key molecule in Type 1 diabetes progression
9. Gestational diabetes not found to alter the metabolic processes in obese pregnant women
10. Lab mice rescued from Type 1 diabetes via dendritic cell-assisted therapy
11. Study links diabetes and colorectal cancer

Post Your Comments:
(Date:5/22/2013)... Early screening for prostate cancer could become as ... women, thanks to UC Irvine research published today in ... , After more than a decade of work, UC ... clinically usable markers for prostate cancer in urine, meaning ... greater accuracy and at dramatically lower cost. The same ...
(Date:5/21/2013)... monitoring" device attached to a whale entangled in fishing ... lines changed a whale,s diving and swimming behavior. The ... eat and migrate, depletes their energy as they drag ... a slow death. , The scientists in this entanglement ... a two-year-old female North Atlantic right whale called Eg ...
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Drugs found to both prevent and treat Alzheimer's disease in mice 2
(Date:5/21/2013)... 22, 2013 First patients dosed ... glycopyrronium bromide designed using Prosonix, particle engineering platform ... portfolio of inhaled Respiratory Medicines by Design , ... that will assess its effect on lung function and ... with moderate to severe chronic obstructive pulmonary disease (COPD). ...
(Date:5/21/2013)... new study led by George Washington University Professor ... of ice in small droplets is strongly size-dependent, ... the nanoscale. The formation of ice at the ... whose answer also has important implications for climate ... of ice from supercooled water is generally initiated ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Smarter Security, ... security solutions, today announced that Genzyme, a Sanofi company ... of Door Detective® CL for a multi-use facility in ... in four other Genzyme buildings, this latest order underscores ... the tailgate detection device improving doorway access ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: